UNSPSC 42142112: Therapeutic paraffin baths

In this classification, this commodity indicates a product that is designed to apply heat to the hands or feet through the use of paraffin wax. US FDA regulates Therapeutic paraffin baths under 21 CFR 890.5110 and under FDA product code IMC. Most nations, for tariff and trade purposes, schedule these products under HS 691010.

UNSPSC 42142112 Therapeutic paraffin baths is a Commodity code that covers therapeutic heating and immersion equipment used in rehabilitation and medical treatment settings. State and local governments procure this equipment primarily through health and human services departments, rehabilitation programs, and institutional care facilities serving populations with traumatic injuries, chronic pain, post-surgical recovery needs, and related therapeutic applications. The code sees sporadic activity driven by departmental equipment refresh cycles and program expansion rather than routine ongoing demand. Recent state and local solicitations show the equipment being requested as part of broader durable medical equipment (DME) and rehabilitation services contracts rather than as standalone line items, reflecting how health agencies typically consolidate medical equipment procurement across multiple modalities to streamline vendor management and compliance oversight.

The Texas Health and Human Services Commission's RFP HHS0017173, posted June 2, 2026, exemplifies current buying patterns under this code. HHSC is establishing master contracts for DME and Services supporting the Comprehensive Rehabilitation Services program for individuals with traumatic brain injuries and spinal cord injuries across eleven geographic service regions throughout Texas. Therapeutic paraffin baths would fall within the equipment category under this procurement, which encompasses respiratory supplies, orthotics and prosthetics, positioning devices, wheelchairs, and biofeedback devices, with contract value capped at $5 million over five years. The procurement requires current medical device manufacturer or distributor licensages, two years in business, and compliance with CMS DMEPOS fee schedules; proposals were due June 2, 2026. The opportunity includes a Texas HUB set-aside with a 21.1 percent utilization goal. Activity under this code remains concentrated in Texas and other states with large rehabilitation service networks and aging institutional care populations, but recent posting volume does not indicate sustained high-frequency procurement activity across jurisdictions.